Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
D006585:Altretamine / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007958:Leukocyte Count; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008937:Mitomycins / Q000627:therapeutic use; D014747:Vinblastine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014751:Vindesine
D000970:Antineoplastic Agents; D008937:Mitomycins; D014747:Vinblastine; D006585:Altretamine; D014751:Vindesine